Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drug

David S. Alberts, Katherine S. Griffith, Gary E. Goodman, Terence S. Herman, Edward Murray

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drug'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds